Published in PLoS One on November 18, 2011
ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell (2013) 2.32
Array-based sensing of metastatic cells and tissues using nanoparticle-fluorescent protein conjugates. ACS Nano (2012) 0.98
The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer. PLoS One (2014) 0.98
Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.88
Mutation scanning using MUT-MAP, a high-throughput, microfluidic chip-based, multi-analyte panel. PLoS One (2012) 0.87
Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas. PLoS One (2012) 0.87
Challenges in Biomarker Discovery: Combining Expert Insights with Statistical Analysis of Complex Omics Data. Expert Opin Med Diagn (2013) 0.86
Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation. Gut (2013) 0.84
Metabolomics method to comprehensively analyze amino acids in different domains. Analyst (2015) 0.81
Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressiveness. F1000Res (2015) 0.80
Increased lymph node yield in colorectal cancer is not necessarily associated with a greater number of lymph node positive cancers. PLoS One (2014) 0.80
Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer. Dis Markers (2016) 0.78
14-3-3β Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells by Modulating Expression of MMP2 and MMP9 through PI3K/Akt/NF-κB Pathway. PLoS One (2016) 0.77
Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer. Oncotarget (2016) 0.76
A Comprehensive Study of Extramural Venous Invasion in Colorectal Cancer. PLoS One (2015) 0.75
Pattern-based sensing of triple negative breast cancer cells with dual-ligand cofunctionalized gold nanoclusters. Biomaterials (2016) 0.75
A Proteomics Analysis Reveals 9 Up-Regulated Proteins Associated with Altered Cell Signaling in Colon Cancer Patients. Protein J (2017) 0.75
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
Colorectal cancer. Lancet (2010) 8.36
Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res (2009) 6.43
Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst (2009) 4.42
Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer (2009) 3.99
The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol (2008) 3.30
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol (2008) 2.80
Matrix metalloproteinases in tumour invasion and metastasis. J Pathol (1999) 2.65
The 14-3-3 cancer connection. Nat Rev Cancer (2003) 2.36
Colorectal cancer molecular biology moves into clinical practice. Gut (2010) 2.32
Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. Eur J Cancer (2010) 2.16
Current and emerging concepts in tumour metastasis. J Pathol (2010) 1.88
Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics (2004) 1.82
The role of annexins in tumour development and progression. J Pathol (2008) 1.75
Tumour markers of prognosis in colorectal cancer. Br J Cancer (1999) 1.68
Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Br J Cancer (2006) 1.65
Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer (2007) 1.61
Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol (2005) 1.53
A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned? Eur J Cancer (2009) 1.45
Oncogenic mutations as predictive factors in colorectal cancer. Oncogene (2010) 1.45
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res (2004) 1.29
Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Clin Cancer Res (2005) 1.25
MicroRNAs as biomarkers in colorectal cancer. Am J Pathol (2010) 1.25
Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin Cancer Res (2005) 1.22
The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase. BMC Cancer (2005) 1.22
60KDa chaperonin (HSP60) is over-expressed during colorectal carcinogenesis. Eur J Histochem (2003) 1.20
Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer. J Pathol (2006) 1.20
Profiling markers of prognosis in colorectal cancer. Clin Cancer Res (2006) 1.17
Analysis of key cell-cycle checkpoint proteins in colorectal tumours. J Pathol (2002) 1.17
Biomarker-based prediction of response to therapy for colorectal cancer: current perspective. Am J Clin Pathol (2010) 1.13
Molecular predictive and prognostic markers in colon cancer. Cancer Treat Rev (2010) 1.11
Liver fatty acid binding protein expression in colorectal neoplasia. Br J Cancer (2004) 1.10
Profiling the expression of cytochrome P450 in breast cancer. Histopathology (2010) 1.08
A novel binding factor of 14-3-3beta functions as a transcriptional repressor and promotes anchorage-independent growth, tumorigenicity, and metastasis. J Biol Chem (2008) 1.05
Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. J Proteomics (2010) 1.04
The expression profile of RNA-binding proteins in primary and metastatic colorectal cancer: relationship of heterogeneous nuclear ribonucleoproteins with prognosis. Hum Pathol (2010) 1.01
Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. Clin Cancer Res (2000) 0.99
Molecular markers in the treatment of metastatic colorectal cancer. Cancer J (2010) 0.99
Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma. FEBS J (2010) 0.99
Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer. Gut (2010) 0.98
Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology. J Proteome Res (2009) 0.96
Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. Electrophoresis (1999) 0.93
Proteomics-based identification of HSP60 as a tumor-associated antigen in colorectal cancer. Proteomics Clin Appl (2007) 0.87
Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist. Surg Oncol (2008) 0.87
Spot the differences: proteomics in cancer research. Lancet Oncol (2001) 0.87
Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers. Nat Clin Pract Gastroenterol Hepatol (2009) 0.83
Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease. BMC Cancer (2010) 0.81
Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology. Int J Oncol (2010) 0.77
ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell (2013) 2.32
Cytochrome P450 enzymes: novel options for cancer therapeutics. Mol Cancer Ther (2004) 2.20
The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta (2005) 2.15
Current and emerging concepts in tumour metastasis. J Pathol (2010) 1.88
The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol (2002) 1.78
Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol (2006) 1.67
The inflammatory microenvironment in colorectal neoplasia. PLoS One (2011) 1.62
Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol (2005) 1.53
Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clin Cancer Res (2004) 1.36
The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer. J Natl Cancer Inst (2011) 1.34
New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol (2003) 1.31
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res (2004) 1.29
Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1. PLoS Pathog (2013) 1.27
Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Clin Cancer Res (2005) 1.25
Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin Cancer Res (2005) 1.22
Profiling markers of prognosis in colorectal cancer. Clin Cancer Res (2006) 1.17
Analysis of key cell-cycle checkpoint proteins in colorectal tumours. J Pathol (2002) 1.17
Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms. Biochem J (2005) 1.11
Target validation of cytochrome P450 CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissue. Int J Radiat Oncol Biol Phys (2004) 1.08
Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities? PLoS One (2011) 1.08
Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis. Cancer Res (2012) 1.02
The expression profile of RNA-binding proteins in primary and metastatic colorectal cancer: relationship of heterogeneous nuclear ribonucleoproteins with prognosis. Hum Pathol (2010) 1.01
The candidate oncogene ZNF217 is frequently amplified in colon cancer. J Pathol (2004) 1.01
Tumor transcriptome reveals the predictive and prognostic impact of lysosomal protease inhibitors in non-small-cell lung cancer. J Clin Oncol (2006) 0.99
Cytochrome P450 1B1: a novel anticancer therapeutic target. Future Oncol (2005) 0.97
APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling. BMC Cancer (2009) 0.94
Dectin-1 is not required for controlling Candida albicans colonization of the gastrointestinal tract. Infect Immun (2012) 0.93
The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers. Histopathology (2009) 0.92
Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases. Hum Pathol (2002) 0.90
The use of formalin fixed wax embedded tissue for proteomic analysis. J Clin Pathol (2011) 0.89
CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasia. Oncol Rep (2002) 0.88
Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes' B colorectal cancer patients. Histopathology (2013) 0.88
Candida albicans colonization and dissemination from the murine gastrointestinal tract: the influence of morphology and Th17 immunity. Cell Microbiol (2014) 0.86
Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia. Saudi Med J (2004) 0.85
Laser capture microdissection and PCR for analysis of human papilloma virus infection. Methods Mol Biol (2005) 0.84
Biomarkers of colorectal cancer: recent advances and future challenges. Proteomics Clin Appl (2015) 0.84
Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation. Gut (2013) 0.84
Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: a case-control and immunohistochemical study. BMC Res Notes (2012) 0.83
Isolated tuberculosis of the liver: a diagnostic challenge. BMJ Case Rep (2011) 0.83
Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer. J Pathol (2012) 0.83
Primary colorectal tumour is not an accurate predictor of thymidylate synthase in lymph node metastasis. Oncol Rep (2002) 0.83
Progress in the identification of plasma biomarkers of colorectal cancer. Proteomics (2013) 0.83
Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target. Clin Cancer Res (2007) 0.81
Quantitative analysis of the Ah receptor/cytochrome P450 CYP1B1/CYP1A1 signalling pathway. Biochem Pharmacol (2003) 0.81
The proteomics of formalin-fixed wax-embedded tissue. Clin Biochem (2012) 0.80
Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma. J Pathol (2004) 0.80
Cytochrome P450 enzymes and tumor therapy. Mol Cancer Ther (2004) 0.78
The influence of bisnaphthalimidopropyl polyamines on DNA instability and repair in Caco-2 colon epithelial cells. Cell Biol Toxicol (2011) 0.78
The role of gene regulatory networks in promoting cancer progression and metastasis. Future Oncol (2014) 0.76
An introduction to laser-based tissue microdissection techniques. Methods Mol Biol (2005) 0.76
Has the proteome of formalin-fixed wax-embedded tissue been unlocked? Nephrol Dial Transplant (2012) 0.75
Familial collagenous colitis involving a 6-year old child. J Crohns Colitis (2011) 0.75
Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia. Ann Saudi Med (2004) 0.75
The Journal of Pathology 2008 Jeremy Jass Prize for Research Excellence in Pathology. J Pathol (2009) 0.75